Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q3 2024 Earnings

30AugConfirmed
Q2 2023
Q3 2023
Q2 2024
Q3 2024
0
0.13
0.25
0.38

Details

Expected EPS
0.33256890767999997
Actual EPS
0.3754810248
Surprise EPS
0.04
Surprise Percent
+12.9%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.3754810248 per share for Q3 2024.

0 Comments

Share your thoughts